Susan E. Burwig - Jun 14, 2021 Form 4 Insider Report for Medpace Holdings, Inc. (MEDP)

Role
Exec. VP, Operations
Signature
/s/ Stephen P. Ewald, Attorney-in-Fact for Susan E. Burwig
Stock symbol
MEDP
Transactions as of
Jun 14, 2021
Transactions value $
-$2,298,934
Form type
4
Date filed
6/16/2021, 04:15 PM
Next filing
Sep 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MEDP Common Stock Options Exercise $170K +7.4K +10.57% $23.00* 77.4K Jun 14, 2021 Direct F1
transaction MEDP Common Stock Sale -$1.32M -7.4K -9.56% $179.02 70K Jun 14, 2021 Direct F1, F2
transaction MEDP Common Stock Options Exercise $215K +7.6K +10.86% $28.32* 77.6K Jun 14, 2021 Direct F1
transaction MEDP Common Stock Sale -$1.36M -7.6K -9.79% $178.90 70K Jun 14, 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MEDP Employee Stock Option (Right to Buy) Options Exercise $0 -7.4K -100% $0.00* 0 Jun 14, 2021 Common Stock 7.4K $23.00 Direct F4
transaction MEDP Employee Stock Option (Right to Buy) Options Exercise $0 -7.6K -38% $0.00 12.4K Jun 14, 2021 Common Stock 7.6K $28.32 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a limit order by the Reporting Person.
F2 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $178.50 to $179.33. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
F3 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $178.43 to $179.51. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
F4 Each option vested on August 10, 2020.
F5 Each option vested on March 15, 2021.